GLP-1 Receptor Agonist Market
The global GLP-1 receptor agonist market is surging, driven by rising type 2 diabetes and obesity rates. Valued at ~USD 53.5 billion in 2024, it’s projected to reach ~USD 156.7 billion by 2030, with a CAGR of ~17.5%. North America dominates, with semaglutide leading. Website URL: https://www.imarcgroup.com/glp-1-receptor-agonist-market Country List: United States